OTC Drugs: U.S. Competitor Cost Structures 2010
Published September 2010
View PDF brochure
View
fact sheet
The report presents information on the financial performance,
profitability, and costs structures of the ten leading
OTC companies in the United States for 2008 and 2009.
It is designed to help OTC pharmaceutical companies
benchmark their cost structures with those of their
competitors. For each company, cost breakdowns are provided
for its overall OTC business, as well as its leading
product classes. (Y617B)
TABLE OF CONTENTS |
 |
|
 |
|
|
Introduction
Executive Summary
State of the industry
Impacts on the industry from the recession
Market sales and growth
Industry cost structure
Key factors influencing profitability
Analysis of key expenses
Competitive landscape/impact of mergers on costs structures
Product class cost structures
Appraisal and Outlook
Company Profiles
Corporate overview
Corporate sales and profits
Business unit cost structure
Cost structure of leading product classes
Appraisal |
Contact
|
